Quoin Pharmaceuticals Ltd...

NASDAQ: QNRX · Real-Time Price · USD
7.50
0.20 (2.67%)
At close: Aug 15, 2025, 3:34 PM
7.48
-0.20%
After-hours: Aug 15, 2025, 04:04 PM EDT

Quoin Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-3.7M -3.81M -2.31M -2.35M -1.97M -2.35M -2.07M -1.93M -2.11M -2.6M -2M -3.03M -2.67M -1.68M -11.82M -1.4M -4.34M -3.9M
Depreciation & Amortization
25K 25K 25.2K 24.82K 24.91K 25K 25.95K 26.01K 26.01K 26.01K 26.01K 26.01K 26.01K 26.01K 26.01K 26.01K 26.01K 26.01K
Stock-Based Compensation
321.49K 360.36K 326.33K 313.12K 313.12K 306.31K 300.2K 268.5K 264.38K 261.47K 267.28K 267.28K 229K n/a n/a n/a n/a n/a
Other Working Capital
260.12K 225.03K -597.42K 376.76K -76.21K 16.13K -393.25K 163.14K 166.88K -584.99K -395.33K 641.79K -17.34K -105.66K -534.95K 296.68K 202.51K 17.09K
Other Non-Cash Items
-83.63K -67.06K -65.28K -64.65K -22.94K -78.5K 1.24M -138.71K -97.13K -133.62K 229.97K 390.33K 229.44K -493.24K 8.26M -146.81K 3.16M 3.04M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -1.34M n/a n/a n/a n/a n/a -229 n/a n/a n/a n/a n/a
Change in Working Capital
-253.25K 899.71K -211.5K -102.7K -353.25K 665.91K -1.38M 449.35K 340.97K 702.67K -464.65K 52.48K 261.35K 56.47K 350.73K 617.4K -66.63K 427.62K
Operating Cash Flow
-3.69M -2.59M -2.24M -2.18M -2M -1.43M -3.22M -1.32M -1.57M -1.75M -1.94M -2.29M -2.15M -2.09M -3.18M -907.54K -1.22M -413.73K
Capital Expenditures
3.27 n/a n/a n/a n/a 4.43 n/a n/a n/a n/a 250K 1.64K -200K -50K -250K -107.5K -125K -142.5K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a -6M -1.61M 68.39K -9.65M -177.68K -4.6M 9.8K -13.49M -66.76K -9.79M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
-2.77M 2.94M 2.82M 4.21M 3.13M 5.18M 2.81M 4.6M 3.04M 10M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
4.45M -172.96K n/a -2.33K -44.29K n/a n/a n/a -9.8K -3.49K -10.14B -107.13K -200 -50K -250K -107.5K 141.02K -141.02K
Investing Cash Flow
1.68M 2.77M -3.18M 2.6M 3.15M -4.47M 2.63M 821.00 3.04M -3.49M -10.14B -9.9M -200K -50K -250K -107.5K -125K -142.5K
Debt Repayment
n/a -150K -150K -150K -150K -150K -150K -275K n/a n/a n/a n/a n/a n/a n/a n/a 2.06M 1.41M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -65.27M n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-150K 899.00 -39.24K 6.36K 462.00 -60.82K -90.03K 13.52K -75K 5.75M -520.25K 14.75M -150K -150K 10.26M -52.77K -76.97K -100.02K
Financial Cash Flow
-150K 22.96K 5.92M -149.89K -174.61K 5.33M -182.58K -275K -75K 5.75M -446.86K 14.75M -150K -150K 10.26M -52.77K 1.99M 1.31M
Net Cash Flow
-2.15M 198.78K 506.59K 271.62K 1.01M -567.68K -762.16K -1.6M 1.39M 511.23K -2.39M 2.56M -2.5M -2.29M 6.83M -1.07M 642.8K 753.75K
Free Cash Flow
-3.69M -2.59M -2.24M -2.18M -2M -1.45M -3.26M -1.32M -1.57M -1.75M -1.69M -2.29M -2.35M -2.14M -3.43M -1.02M -1.35M -556.23K